Come and meet us at FOB 23 from 10 to 12 October, Basel.

We are pleased to announce our participation in the upcoming Festival of Biologics 2023 (FOB) from October 10th to 12th in Basel, Switzerland. Oncofactory is teaming up with Voxcan, both proud members of the ERBC group.

Raafat Fares, Scientific Director, ERBC group, Eleonora Mattei, Scientific Business Development Manager, ERBC Group and Julia Matonti, Business Development Manager, ERBC Group, Voxcan, are looking forward to meeting you to discuss our extensive non-clinical expertise and how we can build a new partnership to accelerate your candidate’s time to market in line with the 3Rs principles, as our offering includes:

  • A unique AVI-PDX platform, based on the generation of patient tumor replicas in avian embryos, combined with state-of-the-art 3D microscopy and large-scale molecular analysis for rapid efficacy assessment and in-depth mechanism of action characterization to evaluate therapeutic candidates.
  • Non-invasive in vitro and in vivo models, coupled with high-resolution imaging across various small animal species. These capabilities are tailored for non-clinical drug development, covering areas such as oncology, viral and bacterial infectious diseases, osteo-articular inflammatory diseases, and medical devices. We specialize in conducting efficacy, biodistribution, mechanistic, and proof of concept studies.

Visit our team at the French Biotherapy Pavilion, promoted by Choose France, on booth #6.